ENDO3 Trial with Andreas Obermair


Manage episode 302178592 series 1426075
Зроблено BMJ talk medicine and BMJ Group і знайдено завдяки Player FM та нашій спільноті. Авторські права належать видавцю, а не Player FM, і аудіоматеріали транслюються безпосередньо з сервера видавця. Натисніть на кнопку Підписатися, щоб слідкувати за оновленнями в Player FM або скопіюйте і вставте посилання на канал до іншої програми для подкастів.
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Andreas Obermair to discuss the ENDO3 Trial. Dr. Obermair is a gynaecological oncologist in Brisbane, Australia, promoting surgery with proven better patient outcomes. Highlights •ENDO3 exemplifies the need to question current standard clinical practice if this practice – while performed routinely - has not shown patient benefit. •ENDO3 employs meticulous methodology and has been designed with input from gynaecological oncologists, medical and radiation oncologists, behavioural scientists, exercise physiologists, statisticians, translational scientists, including the patient perspective. •ENDO3 will offer unique insights into clinically meaningful outcomes that will shape our approach to surgical treatment of endometrial cancer in the future. Andreas Obermair (@AndreasObermair / @UQ_gynae_cancer)

3655 епізодів